Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02177058 · ClinicalTrials.gov registry record · NA
Reducing Hospitalizations of Nursing Home Residents
A NA study of Unnecessary Hospitalizations of Nursing Home Residents, sponsored by Florida Atlantic University.
- Completed
- Registry status
- NA
- Development phase
- 264
- Enrollment target
- 1
- Study location
NCT02177058: Completed NA study of Unnecessary Hospitalizations of Nursing Home Residents, sponsored by Florida Atlantic University.
NCT02177058 is a NA study of Unnecessary Hospitalizations of Nursing Home Residents that has completed, run by Florida Atlantic University. The registered enrollment target is 264 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02177058, a NA study of Unnecessary Hospitalizations of Nursing Home Residents, has completed, sponsored by Florida Atlantic University.
- COMPLETED
- Registry status
- NA
- Development phase
- 264 participants
- Enrollment target
- 1
- Study location
Study Summary
This project directly addresses the national imperative for innovative strategies to improve care for Medicare beneficiaries and reduce health care costs. The overall objective of the proposed project is to improve the care of older individuals who reside in nursing homes (NHs), and at the same time reduce unnecessary Medicare expenditures. This goal will be accomplished by testing a quality improvement program designed to reduce the number of avoidable hospitalizations of NH residents in a randomized controlled trial. The primary hypotheses to be tested are: Hypothesis1: Interventions to Reduce Acute Care Transfers (INTERACT) implementation NHs will have a greater reduction in hospitalization rate than the control and monitoring only NHs during the 12-month implementation compared to a 12-month baseline period. Hypothesis 2: Reductions in Medicare expenditures for hospitalizations in the INTERACT implementation NHs will be greater than the estimated costs of implementing the intervention. Hypothesis 3: The effects of INTERACT on hospitalization rates will be greater among patients on the Medicare skilled benefit for post-acute care, than for long-stay patients. Hypothesis 4: The effects of INTERACT on hospitalization rates will be greatest among those NHs with higher vs. lower intensity (fidelity) of implementing the program. Hypothesis 5: There will be a greater reduction in measures of hospitalizations for conditions defined as "potentially preventable" than for other transfers and hospitalizations. Hypothesis 6: Implementation of INTERACT will not be associated with worsening of relevant quality measures in the participating NHs.
Conditions Studied
Interventions
- OTHER INTERACT Quality improvement program
- OTHER Quarterly surveys/data reporting
Study Locations (1)
Florida
- Florida Atlantic University, College of Medicine/College of Nursing - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2012-01 |
| Est. Completion | 2021-02-28 |
| Phase | NA |
What the finished NCT02177058 record still lists
NCT02177058 is an interventional study that assigns participants to a tested intervention. The registered 264 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Unnecessary Hospitalizations of Nursing Home Residents appearing as the primary indexed condition, and to 2 interventions - of which INTERACT Quality improvement program is the first listed.
NCT02177058 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02177058 about?
NCT02177058 is a clinical study titled "Reducing Hospitalizations of Nursing Home Residents". This project directly addresses the national imperative for innovative strategies to improve care for Medicare beneficiaries and reduce health care costs. The overall objective of the proposed project is to improve the care of older individuals who reside in nursing homes (NHs), and at the same time...
What is the current status of trial NCT02177058?
This trial is currently completed. It is a NA study. The enrollment target is 264 participants. The study started on 2012-01. Estimated completion is 2021-02-28.
What conditions does trial NCT02177058 study?
This clinical trial studies the following conditions: Unnecessary Hospitalizations of Nursing Home Residents.
What interventions are being tested in trial NCT02177058?
The interventions under investigation include: INTERACT Quality improvement program (OTHER), Quarterly surveys/data reporting (OTHER).
Who is sponsoring clinical trial NCT02177058?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02177058 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02177058's enrollment target sits among peer trials
264 395th of 2000 higher than 1,605 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
- NCT04295863 · 264 participants · Phase 1
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
- NCT05220202 · 264 participants · NA
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression
- NCT05473013 · 264 participants · NA
Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia